Copyright: ©Author(s) 2026.
World J Clin Cases. Sep 6, 2026; 14(25): 125054
Published online Sep 6, 2026. doi: 10.12998/wjcc.125054
Published online Sep 6, 2026. doi: 10.12998/wjcc.125054
Table 1 Demographics and medical comorbidities for body mass index ≥ 40 vs body mass index < 30 cohorts before and after propensity score matching, n (%)/mean ± SD
| Before PSM | After PSM | |||||||
| BMI ≥ 40 | BMI < 30 | P value | SMD | BMI ≥ 40 | BMI < 30 | P value | SMD | |
| Age | 60.5 8.4 | 69.5 10.0 | < 0.001 | 0.968 | 60.9 8.2 | 60.6 8.9 | 0.522 | 0.032 |
| Race | ||||||||
| White | 612 (73.3) | 2953 (80.9) | < 0.001 | 0.182 | 599 (74.2) | 605 (75.0) | 0.732 | 0.017 |
| Black or African American | 156 (18.7) | 274 (7.5) | < 0.001 | 0.336 | 143 (17.7) | 138 (17.1) | 0.743 | 0.016 |
| Asian | 10 (1.2) | 108 (3.0) | 0.004 | 0.124 | 10 (1.2) | 0 (0.0) | 0.002 | 0.158 |
| Native Hawaiian or Other Pacific Islander | 0 (0.0) | 10 (0.3) | 0.130 | 0.074 | 0 (0.0) | 0 (0.0) | > 0.999 | < 0.001 |
| American Indian or Alaska Native | 10 (1.2) | 10 (0.3) | < 0.001 | 0.108 | 10 (1.2) | 10 (1.2) | > 0.999 | < 0.001 |
| Other race | 10 (1.2) | 63 (1.7) | 0.276 | 0.044 | 10 (1.2) | 10 (1.2) | > 0.999 | < 0.001 |
| Unknown race | 54 (6.5) | 243 (6.7) | 0.842 | 0.008 | 53 (6.6) | 54 (6.7) | 0.920 | 0.005 |
| Sex | ||||||||
| Male | 200 (24.0) | 1418 (38.8) | < 0.001 | 0.325 | 198 (24.5) | 210 (26.0) | 0.492 | 0.034 |
| Female | 635 (76.0) | 2231 (61.1) | < 0.001 | 0.326 | 609 (75.5) | 597 (74.0) | 0.492 | 0.034 |
| Unknown | 0 (0.0) | 10 (0.3) | 0.130 | 0.074 | 0 (0.0) | 0 (0.0) | > 0.999 | < 0.001 |
| Medical comorbidities | ||||||||
| Mood (affective) disorders | 84 (10.1) | 231 (6.3) | < 0.001 | 0.136 | 79 (9.8) | 64 (7.9) | 0.189 | 0.065 |
| Anxiety disorders | 66 (7.9) | 246 (6.7) | 0.233 | 0.045 | 62 (7.7) | 51 (6.3) | 0.283 | 0.053 |
| Chronic pain syndrome | 10 (1.2) | 13 (0.4) | 0.002 | 0.096 | 10 (1.2) | 10 (1.2) | > 0.999 | < 0.001 |
| Chronic pain | 79 (9.5) | 259 (7.1) | 0.020 | 0.086 | 75 (9.3) | 70 (8.7) | 0.663 | 0.022 |
| Diabetes mellitus | 140 (16.8) | 462 (12.7) | 0.002 | 0.116 | 135 (16.7) | 114 (14.1) | 0.148 | 0.072 |
| Hyperlipidemia (unspecified) | 146 (17.5) | 861 (23.6) | < 0.001 | 0.152 | 144 (17.8) | 111 (13.8) | 0.024 | 0.112 |
| Pure hypercholesterolemia | 66 (7.9) | 464 (12.7) | < 0.001 | 0.159 | 65 (8.1) | 49 (6.1) | 0.120 | 0.077 |
| Essential (primary) hypertension | 293 (35.1) | 1366 (37.4) | 0.207 | 0.049 | 280 (34.7) | 220 (27.3) | 0.001 | 0.161 |
| CKD | 17 (2.0) | 126 (3.5) | 0.036 | 0.087 | 17 (2.1) | 12 (1.5) | 0.349 | 0.047 |
| Nicotine dependence | 18 (2.2) | 78 (2.1) | 0.973 | 0.001 | 18 (2.2) | 16 (2.0) | 0.729 | 0.017 |
| Coronary artery disease | 45 (5.4) | 314 (8.6) | 0.002 | 0.126 | 43 (5.3) | 39 (4.8) | 0.650 | 0.023 |
- Citation: Wu KA, Mai E, Warburton CS, Dhanjani S, Choudhury A, Docters F, Wong L, Prabhat A, Raza M, Maayan O, Song J, Shatkin M, Moucha CS, Hayden BL. Obesity and postoperative opioid utilization after total knee arthroplasty: A propensity-matched analysis. World J Clin Cases 2026; 14(25): 125054
- URL: https://www.wjgnet.com/2307-8960/full/v14/i25/125054.htm
- DOI: https://dx.doi.org/10.12998/wjcc.125054